Bormioli merges parenteral packaging products with Stevanato

Published: 13-Feb-2020

Two Italian companies have combined packaging and filling offerings to overcome challenges in injectable packaging challenges

Stevanato Group, through Ompi, its specialist in glass primary packaging for the pharmaceutical industry, has collaborated with Bormioli Pharma.

The agreement will enable biopharma customers, contract filling organisations, and research laboratories to receive Bormioli’s proprietary primary containers in Ompi’s EZ-fill secondary packaging configuration.

Bormioli Pharma is an Italian pharma primary packaging manufacturer. With seven manufacturing plants and a wide international commercial network, Bormioli Pharma operates in close partnership with the pharmaceutical industry and with all the businesses that are engineering the future of healthcare. The company serves the pharma and biopharmaceutical markets with integrated glass and plastic packaging solutions, always with one single goal in mind: to put health in the hands of the world.

Bormioli glass vials supplied in Ompi’s packaging configurations can be processed into existing fill-finish lines. EZ-fill secondary packaging is designed to mitigate the risk of breakages, cosmetic issues, and particulate generation. It is the ideal solution from lab-scale manual filling up to the traditional filling process, allowing to accelerate the commercialisation of pharmaceutical and biologics.

Andrea Sentimenti, Marketing & Innovation Manager at Bormioli, said that the result of the collaboration “is a premium packaging solution for parenteral drugs, engineered to overcome the challenges of the most demanding injectables”.